The stimulation of IL6 and TNFα production elicited by FGF23 is abolished in diabetic nephropathy mouse models injected with the carboxy-tail peptide of FGF23, which prevents iFGF23 signaling [33]. Here, IL6 is linked to diabetic kidney disease.